Inventys
Generated 5/24/2026
Executive Summary
Inventys is a specialized Indian CDMO providing exclusive manufacturing and contract development services for life-science chemicals, including crop-protection actives, pharmaceutical intermediates, APIs, specialty polymers, and electronic chemicals. Founded in 2005 and headquartered in Mumbai, the company differentiates itself through expertise in flow chemistry, process intensification, and green chemistry, enabling scalable, low-waste production from kilogram to multi-hundred-tonne volumes. Serving diverse end markets—pharmaceuticals, agriculture, and electronics—Inventys benefits from the growing trend of outsourcing to Indian CDMOs, driven by cost advantages and quality compliance. Its commercial-stage operations with 200–500 employees position it as a mid-tier player with established capabilities. The company's focus on sustainable and efficient manufacturing aligns with industry shifts toward greener processes, potentially driving new contract wins and capacity expansions.
Upcoming Catalysts (preview)
- Q3 2026Securing a new exclusive manufacturing contract for a crop-protection active targeting major agrochemical firms65% success
- Q4 2026Completion and operationalization of expanded flow chemistry reactor capacity at its Mumbai facility70% success
- Q2 2026Passing an FDA pre-approval inspection for a pharmaceutical intermediate production line50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)